Loading...
Loading...
Among the 8 tracked institutional investors we monitor, CADL (CANDEL THERAPEUTICS INC) is held with a combined value of $92.51M across 18,526,520 shares. The largest holder is FMR LLC with a position worth $53.84M (0.00% of their portfolio). 4 funds opened new positions in the most recent quarter. 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$92.51M
Total Shares Held
18,526,520
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $53.84M | 0.00% | +33.4% |
| 2 | BlackRock, Inc. | $15.23M | 0.00% | +8.6% |
| 3 | VANGUARD GROUP INC | $13.02M | 0.00% | New |
| 4 | MILLENNIUM MANAGEMENT LLC | $5.19M | 0.00% | New |
| 5 | STATE STREET CORP | $4.01M | 0.00% | +3.3% |
| 6 | CITADEL ADVISORS LLC | $621.15K | 0.00% | -64.6% |
| 7 | Point72 Asset Management, L.P. | $525.33K | 0.00% | New |
| 8 | RENAISSANCE TECHNOLOGIES LLC | $62.62K | 0.00% | New |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of CADL with a position worth $53.84M, representing 0.00% of their portfolio. In total, 8 institutional investors hold CADL with a combined value of $92.51M.
In the most recent quarter, 4 funds opened a new position in CADL. Additionally, 3 increased their holdings and 1 reduced their positions.
Institutional investors hold $92.51M worth of CADL stock across 8 positions. The largest institutional holder is FMR LLC with $53.84M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CADL, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CADL positions.